ibogain
modul
cocain
respons
alter
due
environment
habitu
vivo
microvoltammetr
behavior
studi
pharmacol
biochem
behav
ibogaln
serotonerg
indol
alkaloid
studi
cocain
modulatori
effect
four
paramet
behavior
computer
infrar
photocel
beam
detect
behavior
paramet
locomotor
activ
ambul
b
rear
c
stereotypi
fine
movement
primarili
groom
agoraphobia
thigmotaxi
natur
tendenc
avoid
center
behavior
chamber
behavior
data
point
dopamin
da
releas
serotonin
releas
detect
within
second
nucleu
accumben
nacc
behav
male
spraguedawley
rat
use
vivo
electrochemistri
voltammetri
ibogain
administ
mg
kg
ip
consecut
day
importantli
daergic
respons
sc
cocain
two
behavior
respons
ambul
central
ambul
reduc
intens
due
extend
time
spent
novel
behavior
chamber
habitu
rear
fine
movement
pattern
habitu
result
show
ibogain
downmodul
sc
cocaineinduc
increas
nacc
da
releas
p
potenti
sc
cocaineinduc
decreas
nacc
releas
p
concurr
ibogain
downmodul
cocaineinduc
ambul
p
central
ambul
behavior
p
hand
behavior
paramet
exhibit
habitu
ie
rear
behavior
fine
movement
behavior
downmodul
ibogaln
p
p
respect
furthermor
ibogain
significantli
alter
nacc
da
releas
period
studi
p
although
individu
time
point
significantli
affect
bidirect
concurr
ibogain
significantli
increas
releas
p
behavior
ibogaln
appear
weak
psychostimul
data
show
critic
modulatori
role
ibogainecocaln
interact
also
elucid
critic
efficaci
ibogain
respons
sc
cocain
decreas
due
habitu
anim
environ
cocain
psychostimul
behavior
nucleu
accumben
nacc
dopamin
da
serotonin
vivo
electrochemistri
voltammetri
stearat
microelectrod
freeli
move
rat
paradigm
locomotor
activ
central
locomotor
activ
agoraphob
inhibit
rear
behavior
stereotypi
ibogain
put
treatment
cocain
addict
rather
uniqu
secular
histor
perspect
ibogain
purport
end
crave
process
psychostimul
cocain
narcot
heroin
anecdot
report
given
substanc
issuanc
use
patent
us
offic
patent
result
origin
present
second
annual
intern
behavior
neurosci
societi
confer
held
clearwat
beach
fl
april
request
reprint
address
dr
p
broderick
trademark
present
phase
l
clinic
trial
determin
safeti
pharmacokinet
ibogain
progress
nation
institut
drug
abus
nida
report
activ
support
studi
ascertain
clinic
import
ibogain
ibogain
also
rather
uniqu
scientif
histor
perspect
well
pharmacognosi
chemistri
pharmacolog
pharmacognosi
ibogain
describ
plant
yellowish
root
african
shrub
tabernanth
iboga
baillon
famili
apocynacea
plant
cultiv
gabon
africa
interestingli
either
rare
known
emphas
fact
alkaloid
genera
apocynacea
found
extens
use
modern
medicin
exampl
rauwolfia
alkaloid
wellknown
drug
reserpin
deriv
chemistri
ibogain
place
compound
indol
alkaloid
similar
structur
neurotransmitt
serotonin
ltryptophan
precursor
ibogain
place
ibogain
biochem
pathway
ibogain
first
isol
dybowski
landrin
cite
chemic
structur
ibogain
known
molecular
formula
brain
concentr
ibogain
determin
thin
layer
chromatographi
concentr
ibogain
blood
urin
determin
ultraviolet
spectrophotometr
assay
structur
formula
ibogain
suggest
taylor
confirm
xray
crystallographi
structur
mani
iboga
alkaloid
deduc
ibogain
interestingli
origin
indol
alkaloid
structur
per
se
predic
yohimbin
well
known
antagonist
actual
deriv
fromtryptophan
phenylalanin
formaldehyd
two
mannich
condens
structur
type
alkaloid
apocynacea
eg
isomer
quinindolin
quinindol
quinolin
acid
repres
one
basic
structur
type
studi
peripher
pharmacolog
ibogain
date
mainli
concern
cardiovascular
system
ibogain
found
decreas
blood
pressur
anesthet
anim
increas
blood
pressur
unanesthet
anim
ibogain
found
produc
bradycardia
bradycard
effect
potenti
domperidon
sulpirid
e
receptor
antagonist
atropin
muscarin
cholinerg
antagonist
report
tabernanthin
ibogain
congen
calcium
entri
blocker
also
affect
cellular
calcium
metabol
inhibit
norepinephrin
ne
calcium
induc
vascular
contract
similar
studi
tabernanthin
found
dosedepend
potenti
low
dose
inhibit
high
dose
contract
elicit
ne
mesenter
arteri
action
relat
turnov
intracellular
ca
releas
ne
peripher
tabernanthin
observ
potenti
ca
respons
produc
catecholamin
sensit
isol
rat
duodenum
final
ibogain
produc
hypoglycemia
studi
central
nervou
system
pharmacolog
ibogain
shown
ibogain
produc
tremor
mice
rat
nontremorigen
dose
ibogain
report
mgkg
ip
cappendijk
dzoljic
report
tremorigen
dose
ibogain
mgkg
lower
dose
mgkg
produc
less
promin
shorterlast
behavior
effect
higher
dose
although
shown
ibogain
interact
either
benzodiazepin
receptor
close
relat
gabaa
receptor
tremor
induc
relat
compound
tabernanthin
studi
tabernanthin
act
benzodiazepin
receptor
invers
agonist
vitro
discrimin
bind
assay
addit
tabernanthineinduc
tremor
function
inhibit
benzodiazepin
antagonist
studi
central
nervou
system
pharmacolog
ibogain
shown
ibogain
increas
arous
result
consist
data
sleep
studi
show
ibogain
congen
tabernanthin
tartrat
tabernanthin
parachlorophenoxyacet
sad
provok
increas
wake
level
reduct
level
slow
wave
sleep
transient
block
paradox
sleep
ibogain
congen
tabernanthin
produc
increas
energi
theta
band
frequenc
hz
increas
durat
wake
rat
level
vigil
human
inde
ibogain
report
act
like
antidepress
sleep
paradigm
studi
hallucinatori
effect
ibogain
human
report
cite
dhahir
accord
latter
citat
dr
sigg
describ
experi
ibogain
follow
visual
hallucin
blue
disk
appear
dark
accompani
mani
symptom
common
hallucinogen
intox
undesir
effect
exhaust
depress
note
control
studi
toxic
effect
ibogain
began
tissu
distribut
excret
studi
done
rat
find
show
ibogain
mgkg
ip
locat
high
concentr
liver
kidney
brain
concentr
ibogain
howev
cumul
ibogain
disappear
rate
inject
dose
per
hour
inject
dose
ibogain
excret
unchang
urin
tissu
blood
ratio
high
suggest
blood
may
specimen
choic
postmortem
toxicolog
analysi
toxicolog
studi
use
chronic
dose
ibogain
show
ibogain
mgkg
ip
caus
signific
patholog
chang
liver
kidney
heart
brain
ibogain
administ
consecut
day
patholog
chang
observ
liver
kidney
ibogain
mgkg
administ
consecut
day
comparison
administ
dose
mgkg
base
consecut
day
sever
damag
kidney
characterist
ischem
coagul
necrosi
occur
recent
find
show
ibogain
high
dose
mgkg
ip
administ
chronic
activ
glial
ceil
distinct
longitudin
zone
cerebellum
caus
degener
purkinj
cell
major
neuron
cerebellar
cortex
interestingli
prior
destruct
inferior
oliv
block
purkinj
cell
destruct
howev
mani
brain
area
ohearn
molliv
found
evid
ibogain
toxic
citat
insofar
ibogain
pharmacolog
addict
concern
studi
abil
ibogain
block
cocain
selfadministr
posit
male
rat
addit
abil
ibogain
block
morphin
selfadministr
also
posit
case
somewhat
discrep
femal
rat
result
show
abil
ibogain
allevi
opiat
withdraw
equivoc
posit
neg
moreov
ibogain
low
dose
mgkg
significantli
affect
cocain
discrimin
ibogain
report
neurochemistri
da
locomotor
behavior
vari
probabl
much
paramet
paradigm
vari
ibogain
affect
extracellular
concentr
da
nacc
male
rat
monitor
microdialysi
techniqu
importantli
postmortem
studi
though
ibogain
decreas
da
level
femal
rat
moreov
ibogain
increas
cocaineinduc
amphetamineinduc
extracellular
concentr
da
nacc
femal
rat
wherea
ibogain
decreas
usual
increas
extracellular
concentr
da
morphin
administr
male
rat
mice
ibogain
reduc
amphetamin
cocaineinduc
locomotor
stimul
studi
done
interact
ibogain
neurochemistri
neurotransmitt
serotonin
except
earli
studi
focuss
hypoxia
importantli
ibogain
produc
sidetosid
head
weav
classic
syndrom
publish
seri
articl
show
cocain
act
presynapt
releas
mechan
alter
synapt
concentr
da
coloc
fashion
pathway
light
microscop
immunocytochem
evid
nerv
termin
show
core
nacc
contain
dens
termin
field
tyrosin
hydroxylas
th
axon
extens
overlap
axon
peripheri
within
core
importantli
studi
region
nacc
ventral
later
anterior
commissur
region
refer
ventrolater
nacc
vlnacc
swanson
cowan
suggest
author
vlnacc
reciproc
connect
ventrai
tegment
area
vta
find
axon
close
proxim
da
neuron
vlnacc
consist
ultrastructur
studi
show
immunoreact
termin
core
shell
medial
nacc
recent
studi
show
promin
asymmetr
junction
form
termin
neuron
project
nacc
contain
tyrosin
hydroxylas
vta
therefor
purpos
present
studi
assess
effect
ibogain
alon
cocaineinduc
alter
da
releas
vlnacc
freeli
move
behav
male
rat
concurr
studi
effect
ibogain
locomotor
activ
paramet
cocaineinduc
psychostimul
behavior
chang
synapt
concentr
da
reflect
presynapt
releas
mechan
vivo
microvoltammetr
studi
use
bl
shown
cocain
increas
da
concentr
presenc
impuls
flow
blocker
result
vivo
microvoltammetr
studi
consist
earlier
studi
describ
dopamin
releas
properti
cocain
wellknown
action
cocain
reuptak
inhibit
process
preclud
paradigm
alter
respons
cocain
due
extend
habitu
anim
novel
environ
chosen
paradigm
close
mimic
clinic
condit
ibogain
mgkg
ip
administ
suspens
consecut
day
day
vivo
voltammetr
behavior
studi
perform
ibogain
sigma
st
loui
mo
suspend
doubli
deioniz
water
stir
least
min
thermolyn
stir
plate
experiment
day
fourth
day
ibogain
inject
stabl
vivo
electrochem
signal
da
evid
ibogain
mgkg
ip
administ
studi
h
exploratori
behavior
complet
baselin
neurotransmitt
releas
stabil
h
administr
ibogain
cocain
sigma
mgkg
sc
dissolv
doubli
deioniz
water
inject
effect
cocain
mgkg
sc
studi
anoth
group
male
spraguedawley
rat
physiolog
salin
cckg
ip
administ
instead
ibogain
sc
cocain
protocol
neurochem
behavior
protocol
remain
result
compar
effect
sc
cocain
da
releas
vlnacc
freeli
move
behav
rat
cocain
sc
inject
preced
salin
studi
import
note
latter
studi
anim
complet
exploratori
behavior
novel
environ
cocain
inject
present
studi
anim
allow
extend
time
period
novel
behavior
chamber
either
inject
cocain
mgkg
sc
inject
salin
bodyweight
kg
ip
given
due
result
extend
habitu
anim
novel
behavior
chamber
daergic
respons
respons
behavior
respons
sc
cocain
hyperact
antiagoraphobia
significantli
chang
therefor
ibogain
studi
effect
sc
cocain
respons
environment
habitu
also
result
rear
behavior
stereotyp
behavior
cocain
inject
affect
environment
habitu
report
studi
done
unrestrain
freeli
move
male
virusfre
spraguedawley
rat
charl
river
kingston
ny
weight
rang
g
time
vivo
electrochem
behavior
studi
anim
fed
purina
rat
chow
water
ad
lib
group
hous
surgeri
individu
hous
surgeri
h
darklight
cycl
maintain
hous
laboratori
rat
throughout
experiment
studi
rat
test
free
follow
virus
sendai
male
spraguedawley
rat
anesthet
pentobarbit
na
mgkg
ip
bodi
temperatur
continu
maintain
aquamat
k
modul
heat
pad
amer
hosp
suppli
edison
n
j
booster
shot
pentobarbit
na
cc
administ
maintain
adequ
anesthesia
corneal
pinnal
leg
flexion
respons
absent
throughout
surgeri
rat
stereotax
implant
stearat
work
microelectrod
ventrolater
vl
nacc
ap
ml
dv
ventrolater
region
posterior
part
nacc
previous
describ
swanson
cowen
agagcl
refer
microelectrod
stainless
steel
auxiliari
microelectrod
place
contact
cortex
work
refer
auxiliari
microelectrod
assembl
held
place
dental
acryl
kadon
caviti
liner
caulk
becker
parkin
dental
suppli
co
inc
ny
broderick
et
al
stearat
microelectrod
past
mixtur
consist
usp
ultra
superior
puriti
carbon
g
ultracarbon
corp
bay
citi
mi
extra
heavi
nujol
cc
plough
memphi
tn
stearic
acid
mg
sigma
st
loui
mo
stearat
microelectrod
fabric
pull
teflon
envelop
surround
stainless
steel
wire
medwir
corp
mt
vernon
ny
edg
form
microcav
insid
teflon
well
length
result
teflon
well
diamet
teflon
well
tm
detail
methodolog
microelectrod
assembl
synthesi
past
mixtur
publish
laboratori
microelectrod
specif
differ
publish
other
also
importantli
electrochem
ec
macroelectrod
differ
surfac
ec
properti
microelectrod
thu
ec
phenomenon
catalysi
directli
compar
dopamin
detect
stearat
microelectrod
peak
potenti
v
v
respect
dopamin
detect
within
respect
appear
sequenti
two
separ
waveform
vivo
vitro
voltammogram
dopamin
first
signal
second
signal
detect
time
cours
appli
potenti
eapp
figur
show
voltammogram
sequenti
detect
da
releas
vlnacc
freeli
move
behav
spraguedawley
rat
even
high
concentr
anion
metabolit
da
ie
dihydroxyphenylacet
acid
dopac
detect
high
concentr
ascorb
acid
aa
cofactor
da
biosynthet
pathway
detect
howev
aa
detect
v
differ
peak
potenti
ep
da
neurotransmitt
detect
within
time
period
eao
v
v
metabolit
acid
detect
uric
acid
ua
constitu
brain
similar
electroact
eap
properti
detect
peak
potenti
increas
concentr
da
significantli
affect
either
signal
voltammogram
complet
within
voltammogram
consist
detect
farada
vivo
electrochem
signal
da
complet
calibr
curv
detect
da
stearat
cc
nujol
microelectrod
previous
publish
laboratori
medium
exchang
techniqu
stearat
microelectrod
medium
exchang
techniqu
perform
microelectrod
vitro
surgic
insert
implant
microelectrod
vivo
procedur
consist
perform
select
preconcentr
analyt
da
onto
microelectrod
surfac
salin
phosphat
buffer
ph
close
semidifferenti
circuit
scan
v
v
nav
three
five
exposur
cell
deposit
method
achiev
optimum
stabl
preconcentr
analyt
improv
select
efficaci
sensit
microelectrod
analyt
electrolyt
environ
vivo
voltammetr
semideriv
studi
consciou
rat
begun
approxim
day
asept
surgic
procedur
perform
experiment
day
anim
place
farada
plexigla
chamber
dimens
x
x
three
microelectrod
assembl
enclos
within
anim
prosthet
acryl
cap
connect
detector
ba
west
lafayett
mean
mercuri
commut
br
re
instr
princeton
n
j
flexibl
cabl
mate
connector
bjm
electron
staten
island
ny
electr
connect
minigard
surg
suppressor
jefferson
electr
magnetek
ny
connect
isol
electr
ground
potenti
appli
work
microelectrod
respect
microelectrod
salin
detectorpotentiostat
interv
complet
one
voltammogram
cell
activ
next
voltammogram
nonfarada
charg
current
elimin
first
scan
initi
appli
potenti
e
v
scan
rate
mv
sec
activ
pattern
analysi
simultan
monitor
sever
differ
respons
occur
spatial
tempor
apm
measur
multipl
concurr
measur
ambul
locomotor
activ
central
ambul
rear
behavior
fine
movement
primarili
groom
movement
male
spraguedawley
rat
detect
x
array
infrar
photobeam
surround
behavior
chamber
photobeam
held
place
aluminum
frame
aluminum
frame
place
inch
plexigla
floor
behavior
cage
x
x
infrar
photobeam
sampl
ibm
comput
defin
xy
posit
anim
within
inch
resolut
outer
exterior
layer
behavior
chamber
consist
copper
provid
farada
shield
vivo
monitor
electrochem
voltammetr
signal
definit
specif
xy
posit
anim
import
xy
posit
calcul
use
defin
anim
posit
one
equal
size
sector
one
unequ
size
region
region
use
descript
measur
eg
entri
spent
center
cage
central
entri
paramet
locomotor
behavior
becom
reliabl
measur
thigmotaxia
ie
agoraphob
respons
consid
equival
fear
moreov
rear
wherein
forepaw
anim
away
floor
period
least
measur
anoth
seri
infrar
photobeam
situat
inch
floor
behavior
chamber
ibm
comput
sampl
statu
beam
circuit
behavior
chamber
everi
ms
system
custom
modifi
version
activ
pattern
monitor
apm
san
diego
instrument
san
diego
ca
paramet
behavior
monitor
concurr
onlin
detect
da
releas
separ
yet
concurr
detect
releas
compon
behavior
monitor
onlin
addit
da
releas
detect
line
test
statist
signific
differ
preand
postibogainecocain
preand
postsalinecocain
analysi
varianc
anova
statview
brain
power
inc
calabasa
ca
moreov
differ
ibogain
control
salin
control
also
determin
anova
anova
follow
post
hoc
test
fisher
plsd
least
squar
differ
scheff
ftest
statview
brain
power
inc
calabasa
ca
determin
hourli
statist
signific
differ
hourli
data
composit
individu
interv
time
cours
data
point
statist
signific
differ
also
calcul
individu
time
cours
data
point
confid
limit
cl
set
pvalu
p
chang
da
valu
drug
salin
visavi
untreat
anim
control
present
percent
chang
wherea
behavior
data
present
frequenc
number
behavior
event
control
repres
actual
detect
time
da
percent
chang
synapt
concentr
da
data
point
repres
current
chang
pa
baselin
similar
principl
vivo
electrochem
detect
appli
actual
detect
time
data
point
percent
chang
synapt
concentr
data
point
repres
measur
electr
current
pa
within
discret
synapt
environ
da
within
vlnacc
within
time
period
final
basal
endogen
salin
cocainealt
da
releas
vlnacc
concurr
paramet
behavior
studi
statist
signific
correl
valu
pearson
product
moment
coeffici
correl
r
polynomi
distribut
statview
brain
power
inc
calabasa
ca
correspond
z
valu
deriv
tabl
z
valu
r
placement
work
microelectrod
vlnacc
confirm
potassium
ferrocyanid
blue
dot
method
formalintranscardi
perfus
ml
salin
current
pass
amperag
time
period
examin
brain
reveal
virtual
damag
brain
tissu
took
place
figur
show
semideriv
voltammogram
basal
da
releas
detect
concurr
vlnacc
peak
potenti
vivo
electrochem
signal
da
lowest
detect
limit
current
possibl
da
nmol
nmol
respect
hourli
data
composit
individu
interv
time
cours
data
point
howev
small
statist
signific
p
cl
initi
decreas
da
releas
follow
small
statist
signific
increas
da
releas
specif
time
interv
time
cours
studi
da
releas
time
point
min
follow
ibogain
inject
significantli
decreas
basal
da
releas
cl
da
releas
time
point
min
follow
ibogain
inject
significantli
increas
basal
da
releas
cl
tempor
resolut
vivo
electrochemistri
allow
select
effect
ibogain
da
releas
detect
b
phase
effect
sc
cocain
ibogain
pretreat
inject
cocain
mgkg
sc
follow
ibogain
studi
produc
signific
increas
da
releas
vlnacc
baselin
anova
f
p
da
releas
significantli
increas
min
p
cl
maxim
increas
p
cl
min
baselin
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
da
releas
signific
h
follow
cocain
inject
fisher
plsd
scheff
f
first
fourth
hour
respect
import
note
salin
ibogain
inject
administ
chronic
day
day
studi
fourth
day
salin
ibogain
inject
vivo
electrochem
signal
da
detect
concurr
salin
group
ibogain
group
inject
either
salin
ibogaln
respect
consecut
day
day
day
studi
p
confid
limit
cl
see
text
anova
statist
mine
releas
studi
concurr
tempor
resolut
respect
vivo
electrochem
signal
da
peak
separ
distinct
onlin
b
phase
effect
sc
cocain
salin
pretreat
inject
cocain
mgkg
sc
follow
salin
studi
caus
signific
decreas
releas
baselin
anova
f
p
releas
significantli
decreas
begin
min
baselin
p
cl
maxim
decreas
baselin
p
cl
min
baselin
post
hoc
analys
show
statist
signific
differ
basal
cocainealt
releas
signific
h
follow
cocain
mgkg
sc
inject
fisher
plsd
scheff
f
first
fourth
hour
respect
n
comparison
effect
salin
effect
ibogain
releas
show
ibogain
significantli
increas
releas
salin
first
hour
follow
baselin
anova
f
p
anova
f
p
first
second
hour
respect
follow
baselin
comparison
effect
cocain
releas
salin
pretreat
vs
ibogain
pretreat
show
ibogain
significantli
potenti
cocaineinduc
decreas
postcocain
time
minut
fig
da
releas
vlnacc
effect
sc
cocain
without
salin
ibogain
pretreat
anim
habitu
extend
habitu
novel
environ
time
period
extend
effect
cocain
mgkg
sc
synapt
concentr
da
vlnacc
cocain
inject
without
immedi
preced
studi
either
salin
ibogain
p
confid
limit
cl
see
text
anova
statist
n
modifi
broderick
reprint
permiss
elsevi
scienc
ltd
significantli
decreas
begin
min
baselin
p
cl
maxim
decreas
baselin
p
cl
min
baselin
statist
comparison
effect
cocain
da
releas
repeat
environment
stimul
extend
time
period
novel
behavior
chamber
effect
without
show
repeat
stimul
respons
sc
cocain
significantli
reduc
anova
f
p
therefor
cocaineinduc
da
releas
significantli
habitu
downmodul
number
hour
anim
spent
behavior
chamber
even
novel
behavior
chamber
importantli
promin
habitu
effect
da
releas
seen
second
hour
b
phase
effect
sc
cocain
ibogain
pretreat
inject
cocain
mgkg
sc
follow
ibogain
studi
caus
signific
increas
cocaineinduc
ambul
frequenc
baselin
anova
f
p
ambul
frequenc
significantli
increas
ambul
baselin
ambul
p
cl
begin
min
ambul
frequenc
maxim
increas
ambul
p
cl
min
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
ambul
frequenc
signific
h
follow
cocain
inject
fisher
plsd
scheff
f
first
fourth
hour
respect
comparison
effect
salin
effect
ibogain
ambul
frequenc
show
ibogain
significantli
increas
ambul
frequenc
second
hour
follow
baselin
anova
f
p
anova
f
p
first
second
hour
respect
follow
baselin
comparison
effect
cocain
salin
pretreat
vs
effect
cocain
ibogain
pretreat
show
ibogain
significantli
reduc
cocain
figur
show
effect
cocain
ambul
behavior
cocain
mgkg
sc
inject
without
immedi
preced
studi
either
salin
ibogain
cocain
mgkg
sc
significantli
increas
ambul
frequenc
anova
f
p
ambul
frequenc
significantli
increas
baselin
ambul
ambul
begin
mark
p
cl
ambul
frequenc
maxim
increas
ambul
p
cl
mark
statist
comparison
effect
cocain
ambul
frequenc
repeat
environment
stimul
without
show
repeat
stimul
respons
sc
cocain
significantli
reduc
anova
f
p
therefor
subsequ
habitu
downmodul
respons
sc
cocain
seen
ambulatori
behavior
paramet
particularli
first
anova
f
p
fourth
hour
anova
f
p
figur
show
effect
salin
cckg
ip
rear
behavior
addit
show
effect
cocain
mg
kg
sc
rear
behavior
follow
salin
studi
studi
done
freeli
move
behav
male
spraguedawley
rat
vlnacc
da
releas
releas
ambulatori
behavior
studi
ie
salinecocain
group
fig
frequenc
ambulatori
behavior
effect
sc
cocain
without
salin
ibogain
pretreat
anim
group
habitu
extend
habitu
novel
environ
time
period
extend
effect
cocain
mgkg
sc
ambulatori
behavior
cocain
administ
without
salin
ibogain
studi
preced
cocain
inject
vlnacc
da
releas
studi
concurr
fig
ambulatori
locomotor
behavior
report
term
frequenc
number
event
p
confid
limit
cl
see
text
anova
statist
n
b
phase
effect
sc
cocain
salin
pretreat
inject
cocain
mgkg
sc
follow
salin
studi
significantli
increas
rear
frequenc
baselin
anova
f
p
rear
frequenc
significantli
increas
rear
baselin
rear
p
cl
begin
min
maxim
increas
rear
p
cl
min
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
rear
frequenc
signific
second
fourth
hour
follow
cocain
mgkg
sc
inject
fisher
plsd
scheff
f
second
fourth
hour
respect
b
phase
effect
sc
cocain
ibogain
pretreat
inject
cocain
mgkg
sc
follow
ibogain
studi
significantli
increas
rear
frequenc
baselin
anova
f
p
rear
frequenc
significantli
increas
rear
baselin
rear
p
cl
begin
min
rear
behavior
maxim
increas
rear
p
cl
rain
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
rear
frequenc
signific
h
follow
cocain
inject
fisher
plsd
scheff
f
first
fourth
hour
respect
comparison
effect
salin
effect
ibogain
rear
behavior
show
signific
differ
rear
frequenc
either
hour
h
follow
baselin
anova
f
p
anova
f
p
first
second
hour
respect
follow
baselin
comparison
rear
effect
cocain
salin
pretreat
vs
ibogain
pretreat
show
signific
differ
salin
ibogain
cocain
effect
rear
frequenc
anova
f
p
h
follow
cocain
inject
figur
show
effect
cocain
rear
behavior
cocain
mgkg
sc
inject
without
immedi
preced
studi
h
either
salin
ibogain
cocain
significantli
increas
rear
frequenc
baselin
anova
f
p
rear
frequenc
significantli
increas
baselin
rear
rear
begin
min
p
cl
rear
behavior
maxim
increas
rear
p
cl
min
statist
comparison
rear
effect
cocain
studi
repeat
environment
stimul
without
show
signific
differ
two
anova
f
p
therefor
psychostimul
rear
behavior
induc
cocain
exhibit
habitu
respons
cocain
seen
neurochem
respons
cocain
behavior
ambulatori
respons
sc
cocain
therefor
ibogain
downmodul
cocaineinduc
rear
behavior
respons
habitu
figur
show
effect
salin
cckg
ip
frequenc
stereotypi
fine
movement
behavior
addit
show
effect
cocain
mgkg
sc
fine
movement
behavior
follow
salin
studi
studi
done
freeli
move
behav
male
spraguedawley
rat
vlnacc
da
releas
concurr
detect
well
anim
psychostimul
cocaineinduc
behavior
ambul
rear
behavior
concurr
monitor
caineinduc
fine
movement
frequenc
signific
second
fourth
hour
follow
cocain
inject
fisher
plsd
scheff
f
second
fourth
hour
respect
figur
also
show
time
cours
effect
ibogain
mgkg
ip
fine
movement
frequenc
addit
show
effect
cocain
mgkg
sc
fine
movement
frequenc
follow
ibogain
studi
studi
done
freeli
move
behav
male
spraguedawley
rat
vlnacc
da
releas
ambulatori
rear
behavior
studi
concurr
ibogainecocain
group
phase
effect
sc
ibogain
ibogain
significantli
increas
fine
movement
frequenc
first
hour
h
follow
baselin
anova
f
p
ibogain
significantli
increas
fine
movement
frequenc
min
mark
p
cl
ibogain
similar
effect
salin
within
first
min
due
arous
anim
sinc
exploratori
behavior
complet
rest
ensu
b
phase
effect
sc
cocain
ibogain
pretreat
inject
cocain
mgkg
sc
follow
ibogain
studi
produc
significantli
increas
fine
movement
frequenc
baselin
anova
f
p
fine
movement
frequenc
significantli
increas
fine
movement
baselin
fine
movement
p
cl
begin
min
fine
movement
maxim
increas
fine
movement
p
cl
rain
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
fine
movement
frequenc
signific
h
follow
cocain
inject
fisher
plsd
scheff
f
first
fourth
hour
respect
comparison
effect
salin
effect
ibogain
fine
movement
frequenc
show
ibogain
significantli
increas
fine
movement
frequenc
salin
second
hour
anova
f
p
anova
f
p
first
second
hour
respect
howev
comparison
effect
cocain
salin
pretreat
vs
ibogain
pretreat
show
signific
differ
salin
ibogain
cocaineinduc
fine
movement
behavior
anova
f
p
h
follow
cocain
inject
howev
ibogain
significantli
increas
cocain
mgkg
sc
effect
fine
movement
frequenc
fine
movement
first
hour
anova
f
p
figur
show
effect
cocain
fine
movement
behavior
cocain
mgkg
sc
inject
without
immedi
preced
h
studi
either
salin
ibogain
fig
fine
movement
behavior
effect
sc
cocain
without
salin
ibogain
pretreat
anim
habitu
extend
habitu
novel
environ
time
period
extend
effect
cocain
mgkg
sc
fine
movement
behavior
cocain
administ
without
immedi
preced
salin
ibogain
studi
vlnacc
da
releas
ambulatori
behavior
studi
concurr
fig
p
confid
limit
cl
see
text
anova
statist
n
p
hourli
data
composit
individu
interv
time
cours
data
point
salin
effect
within
first
min
due
arous
anim
sinc
exploratori
behavior
complet
rest
ensu
b
phase
effect
sc
cocain
salin
pretreat
inject
cocain
mgkg
sc
follow
salin
studi
significantli
increas
central
ambul
frequenc
baselin
anova
f
p
central
ambul
frequenc
significantli
increas
central
ambul
baselin
p
cl
begin
min
central
ambulatori
activ
maxim
increas
central
ambul
p
cl
rain
post
hoc
analys
show
statist
signific
differ
basal
cocaineinduc
central
ambul
frequenc
signific
second
fourth
hour
follow
cocain
mgkg
sc
inject
fisher
plsd
scheff
f
second
fourth
hour
respect
statist
comparison
stereotyp
effect
cocain
studi
repeat
environment
stimul
without
show
signific
differ
anova
f
p
h
follow
cocain
inject
therefor
cocaineinduc
fine
movement
respons
exhibit
habitu
effect
similar
rear
thu
ibogain
downmodul
cocaineinduc
stereotyp
behavior
respons
respons
habitu
ibogain
central
ambul
agoraphobia
inhibit
n
respect
vlnacc
da
releas
ambul
rear
behavior
fine
movement
central
ambul
concurr
monitor
fig
phase
paramet
exactli
describ
fig
cocaineinduc
effect
da
releas
paramet
concurr
monitor
p
confid
limit
cl
see
text
anova
statist
tori
rear
fine
movement
behavior
studi
concurr
figur
show
effect
cocain
central
ambul
behavior
cocain
mgkg
sc
inject
without
immedi
preced
studi
h
either
salin
ibogain
cocain
significantli
increas
central
ambul
frequenc
baselin
anova
f
p
central
ambul
frequenc
significantli
increas
baselin
two
central
ambul
four
central
ambul
begin
min
mark
p
cl
central
ambul
maxim
increas
central
ambul
p
cl
min
statist
comparison
effect
cocain
central
ambulatori
behavior
studi
repeat
environment
stimul
effect
without
show
f
p
first
fourth
hour
respect
therefor
antiagoraphob
antithigmotact
behavior
thought
repres
reflect
anxiolyt
anxietyreduc
behavior
undergo
habitu
seen
da
respons
ambulatori
respons
importantli
ibogain
downmodul
habitu
behavior
respons
sc
cocain
wherea
behavior
respons
diminish
habitu
significantli
affect
ibogain
figur
show
activ
pattern
habitu
salinecocain
paradigm
describ
fig
ie
cocain
administ
salin
studi
ambulatori
central
ambulatori
moment
shown
initi
stimul
caus
salin
inject
due
arous
shown
first
hour
postsalin
pattern
habitu
respons
cocain
clear
compar
fig
describ
nonhabitu
respons
sc
cocain
ie
addit
time
spent
anim
novel
behavior
chamber
figur
show
activ
pattern
habitu
ibogainecocain
paradigm
ie
cocain
administ
ibogain
studi
ambulatori
central
ambulatori
moment
shown
ibogain
appear
weak
psychostimul
effect
ongo
second
hour
comparison
fig
show
although
cocaineinduc
ambul
reduc
ibogain
pretreat
activ
remain
clearli
greater
seen
salinecocain
group
tabl
show
highli
signific
correl
valu
cocaineinduc
releas
vlnacc
cocaineinduc
psychostimul
behavior
well
highli
correl
valu
cocaineinduc
da
releas
psychostimul
behavior
ibogainecocain
group
tabl
salinecocain
group
tabl
new
find
show
ibogain
significantli
downmodul
cocaineinduc
increas
da
releas
vlnacc
freeli
move
behav
environment
habitu
rat
model
import
distinct
present
studi
previou
studi
present
data
deriv
freeli
move
behav
rat
paradigm
da
respons
sc
cocain
diminish
due
environment
habitu
ie
anim
reduc
respons
da
releas
sc
cocain
presum
due
repeat
environment
stimul
novel
behavior
chamber
moreov
effect
sc
cocain
da
releas
vlnacc
extend
habitu
environ
compar
previou
studi
paradigm
complet
one
except
protocol
extend
habitu
compon
respons
cocain
habitu
environ
fit
classic
definit
neurochem
habitu
ie
repeat
action
potenti
nerv
termin
accompani
behavior
habitu
decreas
number
open
ca
channel
inactiv
synaps
find
habitu
aspect
ibogainecocain
interact
point
necess
crucial
assess
previou
ibogainecocain
literatur
within
context
vari
experiment
paradigm
although
recent
surg
interest
preclin
research
mechan
action
ibogain
two
previou
paper
specif
ibogainecocain
daergic
interact
one
articl
laboratori
glick
us
laboratori
dzoljic
netherland
relev
differ
paradigm
ie
glick
repetit
dose
ibogain
mgkg
ip
c
glick
laboratori
studi
cocaineinduc
extracellular
concentr
da
locomotor
behavior
wherea
dzoljic
laboratori
studi
abil
ibogain
affect
selfadministr
cocain
conclus
consist
potenti
cocaineinduc
increas
extracellular
concentr
da
ibogain
occur
ibogain
administr
h
earlier
longlast
effect
ibogain
report
inhibit
cocain
selfadministr
da
antagonist
classic
increas
rate
cocain
selfadministr
yet
given
certain
caveat
eg
variou
rate
respond
measur
previou
data
may
suggest
ibogain
act
cocain
selfadministr
direct
da
receptor
blockad
consist
present
find
previou
studi
report
ibogain
per
se
significantli
affect
da
releas
nacc
ibogain
effect
extracellular
concentr
da
studi
dialysi
report
maisonneuv
glick
import
note
postmortem
hplcec
assay
ibogain
effect
da
level
later
show
ibogain
decreas
da
level
h
ibogain
inject
nacc
month
later
da
entir
unaffect
ibogain
expectedli
postmortem
assay
may
addit
variabl
compar
result
deriv
vivo
microvoltammetri
dialysi
studi
nonetheless
empir
data
date
show
gener
overal
effect
ibogain
per
se
nacc
da
releas
time
promin
support
ibogain
inabl
affect
da
presynapt
central
nervou
system
glean
reuptak
studi
ie
ibogain
concentr
high
significantli
inhibit
bind
da
transport
protein
ibogain
effect
vitro
striatal
da
reuptak
membran
fraction
b
vivo
treatment
ibogain
affect
bind
win
cocain
bind
site
striatal
tissu
measur
vitro
c
ibogain
ad
vitro
weak
affin
win
bind
site
although
data
base
action
ibogain
da
receptor
incomplet
neither
receptor
rat
striatum
calf
caudat
studi
radioligand
sch
nmethyl
spiperon
respect
affect
ibogain
thu
ibogain
may
act
da
receptor
downmodul
cocain
induc
increas
da
releas
vlnacc
synaps
ibogain
may
act
downmodul
da
releas
synaps
condit
increas
da
releas
andor
reuptak
inhibit
usual
hypox
condit
increas
da
releas
studi
ibogain
da
function
support
latter
hypothesi
thu
ibogain
action
cocaineinduc
da
releas
may
well
depend
avail
da
synaps
least
anim
model
environment
habitu
preliminari
data
laboratori
show
ibogain
may
downmodul
da
releas
vlnacc
cocain
administr
anim
undergon
extend
habitu
environ
habitu
environ
may
key
underli
mechan
action
cocain
da
function
new
find
interact
ibogain
cocain
releas
vlnacc
report
chang
releas
vlnacc
cocain
detect
line
concurr
action
cocain
vivo
detect
da
releas
importantli
sc
cocain
respons
also
habitu
releas
vlnacc
reduc
administr
ibogain
subsequ
potenti
habitu
reduc
respons
vlnacc
seen
sc
cocain
administr
unexpect
find
ibogain
per
se
significantli
increas
releas
vlnacc
shown
fig
interestingli
presenc
sc
cocain
appear
ibogain
act
synaps
decreas
less
avail
priori
effect
cocain
releas
administ
sc
vs
ip
vlnacc
differ
wherea
sc
cocain
decreas
releas
vlnacc
freeli
move
behav
rat
ip
cocain
increas
releas
vlnacc
freeli
move
behav
rat
wherea
ibogain
potenti
decreas
releas
induc
sc
cocain
ibogain
also
appear
potenti
ip
cocain
increas
releas
vlnacc
well
preliminari
data
laboratori
thu
ibogain
seem
also
act
releas
depend
avail
synaps
mechan
unlik
da
though
bidirect
far
direct
receptor
subtyp
concern
present
unclear
specif
receptor
subtyp
involv
action
ibogain
recent
behavior
studi
suggest
function
involv
receptor
possibl
function
involv
receptor
stimulu
properti
ibogain
howev
direct
radioligand
bind
studi
use
dpat
mesulergin
ketanserin
show
ibogain
bind
receptor
subtyp
futur
studi
ibogain
interact
subclassif
receptor
may
clarifi
receptor
bind
properti
ibogain
studi
ibogain
interact
subclassif
receptor
current
underway
laboratori
great
deal
discuss
evolv
possibl
ibogain
exert
neurophysiolog
influenc
metabolit
metabolit
iboga
alreadi
studi
antileukem
activ
antitumor
activ
report
although
present
studi
directli
address
metabol
aspect
ibogain
found
ibogain
effect
cocain
mechan
dramat
later
hour
studi
dzoljic
glick
sershen
point
studi
possibl
metabolit
ibogain
deserv
along
line
interest
dimer
vinca
alkaloid
vinblastin
wellknown
antineoplast
agent
undergo
metabol
transform
iboga
human
serum
copper
oxidas
ceruloplasmin
use
chlorpromazin
shuttl
oxid
hand
dimer
vinca
alkaloid
leurosin
consist
iboga
substructur
oxid
thu
studi
activ
metabolit
ibogain
importantli
underway
summarili
present
data
show
ibogain
per
se
releas
vlnacc
potenti
action
cocain
exhibit
highli
correl
valu
cocaineinduc
da
releas
psychostimul
behavior
therefor
data
suggest
ibogain
act
regul
cocain
neuron
activ
da
circuit
critic
though
ibogain
manipul
cocain
effect
biogen
amin
behavior
cocain
respons
habitu
ibogain
effect
role
habitu
respons
cocain
presum
environment
emphas
ibogainecocain
interact
